{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:05:57Z","timestamp":1794002757052,"version":"4.8.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T00:00:00Z","timestamp":1758326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004961","name":"Monterrey Institute of Technology and Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Secretaria de Ciencia Humanidades Tecnologia e Innovacion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.tmrv.2025.150929","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T23:08:45Z","timestamp":1758582525000},"page":"150929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of Granulocyte Transfusions in Treating Neutropenic Infections: A Systematic Review and Meta-Analysis of Intervention Studies"],"prefix":"10.1016","volume":"39","author":[{"given":"Alejandra","family":"L\u00f3pez-Arredondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa\u00fal Karr","family":"de Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Maria","family":"Lampousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8994-8276","authenticated-orcid":false,"given":"Marion E.G.","family":"Brunck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2025.150929_bib0001","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/21505594.2016.1156821","article-title":"Bloodstream infections in neutropenic cancer patients: a practical update","volume":"7","author":"Gustinetti","year":"2016","journal-title":"Virulence"},{"key":"10.1016\/j.tmrv.2025.150929_bib0002","first-page":"513","article-title":"Incidence of chemotherapy-induced neutropenia and current practice of prophylaxis with granulocyte colony-stimulating factors in cancer patients in Spain: a prospective, observational study: Incidence of neutropenia in Spanish cancer patients","volume":"22","author":"Jolis","year":"2013","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.tmrv.2025.150929_bib0003","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00044011-200727060-00002","article-title":"Economic burden of haematological adverse effects in cancer patients: A systematic review","volume":"27","author":"Liou","year":"2007","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.tmrv.2025.150929_bib0004","doi-asserted-by":"crossref","DOI":"10.1200\/JOP.2016.019588","article-title":"Cost of cancer-related neutropenia or fever hospitalizations, United States, 2012","author":"Tai","year":"2017","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.tmrv.2025.150929_bib0005","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/cncr.20983","article-title":"Linde-Zwirble WT. Incidence, cost, and mortality of neutropenia hospitalization associated with chemotherapy","volume":"103","author":"Caggiano","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.tmrv.2025.150929_bib0006","doi-asserted-by":"crossref","first-page":"841","DOI":"10.21037\/jgo.2019.07.03","article-title":"Treatment delays during FOLFOX chemotherapy in patients with colorectal cancer: a multicenter retrospective analysis","volume":"10","author":"Kogan","year":"2019","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.tmrv.2025.150929_bib0007","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.critrevonc.2009.03.004","article-title":"Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: an observational retrospective survey","volume":"72","author":"Repetto","year":"2009","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"10.1016\/j.tmrv.2025.150929_bib0008","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1200\/JCO.22.02224","article-title":"Guideline for the management of fever and neutropenia in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2023 update","volume":"41","author":"Lehrnbecher","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.tmrv.2025.150929_bib0009","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.4049\/jimmunol.1500861","volume":"195","author":"Mehta","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2025.150929_bib0010","doi-asserted-by":"crossref","first-page":"896","DOI":"10.20892\/j.issn.2095-3941.2020.0069","article-title":"Current management of chemotherapy-induced neutropenia in adults: key points and new challenges","volume":"17","author":"Ba","year":"2020","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.tmrv.2025.150929_bib0011","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1080\/10428194.2016.1193859","article-title":"The growing threat of multidrug-resistant gram-negative infections in patients with hematologic malignancies","volume":"57","author":"Baker","year":"2016","journal-title":"Leukemia Lymphoma"},{"key":"10.1016\/j.tmrv.2025.150929_bib0012","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1182\/blood-2015-05-645986","article-title":"Efficacy of transfusion with granulocytes from G-CSF\/dexamethasone\u2013treated donors in neutropenic patients with infection","volume":"126","author":"Price","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2025.150929_bib0013","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005339.pub2","article-title":"Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction","author":"Estcourt","year":"2016","journal-title":"Cochrane Database of Systematic Rev"},{"key":"10.1016\/j.tmrv.2025.150929_bib0014","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003956.pub2","article-title":"Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropenia","author":"Pammi","year":"2011","journal-title":"Cochrane Database of Systematic Rev"},{"key":"10.1016\/j.tmrv.2025.150929_bib0015","article-title":"Granulocyte transfusions for preventing infections in people with neutropenia or neutrophil dysfunction","volume":"2015","author":"Estcourt","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tmrv.2025.150929_bib0016","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/MPH.0b013e318196a6e6","article-title":"Revisiting the use of granulocyte transfusions in pediatric oncology patients","volume":"31","author":"Graham","year":"2009","journal-title":"J Pediat Hematol\/Oncol"},{"key":"10.1016\/j.tmrv.2025.150929_bib0017","doi-asserted-by":"crossref","first-page":"e220","DOI":"10.1097\/MPH.0b013e31821ffdf1","article-title":"Effect and safety of granulocyte transfusions in pediatric patients with febrile neutropenia or defective granulocyte functions","volume":"33","author":"Atay","year":"2011","journal-title":"J Pediat Hematol\/Oncol"},{"key":"10.1016\/j.tmrv.2025.150929_bib0018","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/bmt.2015.53","article-title":"Single-donor granulocyte transfusions for improving the outcome of high-risk pediatric patients with known bacterial and fungal infections undergoing stem cell transplantation: a 10-year single-center experience","volume":"50","author":"Nikolajeva","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.tmrv.2025.150929_bib0019","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.tmrv.2025.150929_bib0020","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014A web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Systematic Rev"},{"key":"10.1016\/j.tmrv.2025.150929_bib0021","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.tmrv.2025.150929_bib0022","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.tmrv.2025.150929_bib0023","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.tmrv.2025.150929_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-1101(1996)11:1<1::AID-JCA1>3.0.CO;2-F","article-title":"Meta-analysis of clinical studies of the efficacy of granulocyte transfusions in the treatment of bacterial sepsis","volume":"11","author":"Vamvakas","year":"1996","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.tmrv.2025.150929_bib0025","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.tmrv.2025.150929_bib0026","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jclinepi.2018.01.012","article-title":"GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence","volume":"111","author":"Sch\u00fcnemann","year":"2019","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.tmrv.2025.150929_bib0027","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archpedi.1988.02150110039016","article-title":"Neonatal neutropenia: clinical manifestations, cause, and outcome","volume":"142","author":"Baley","year":"1988","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.tmrv.2025.150929_bib0028","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1002\/cncr.20710","article-title":"Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: retrospective case-control analysis of 491 episodes of Candida species bloodstream infections","volume":"101","author":"Safdar","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.tmrv.2025.150929_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209832","article-title":"Role of granulocyte transfusions in combating life-threatening infections in patients with severe neutropenia: experience from a tertiary care centre in North India","volume":"13","author":"Garg","year":"2018","journal-title":"Plos One"},{"key":"10.1016\/j.tmrv.2025.150929_bib0030","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.bbmt.2019.04.023","article-title":"Impact of preemptive granulocyte infusions during febrile neutropenia in patients colonized with carbapenem-resistant gram-negative bacteria undergoing haploidentical transplantation","volume":"25","author":"Jaiswal","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.tmrv.2025.150929_bib0031","first-page":"21","article-title":"Controlled study of therapeutic granulocyte transfusions in granulocytopenic patients with severe infections","volume":"14","author":"Matsue","year":"1984","journal-title":"JPN J Clin Oncol"},{"key":"10.1016\/j.tmrv.2025.150929_bib0032","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/mpo.2950060110","article-title":"Granulocyte transfusions in infected neutropenic children with malignancies","volume":"6","author":"Steinherz","year":"1979","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.tmrv.2025.150929_bib0033","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF01640936","article-title":"Infectious episodes in severely granulocytopenic patients","volume":"7","author":"Van Der Meer","year":"1979","journal-title":"Infection"},{"key":"10.1016\/j.tmrv.2025.150929_bib0034","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/mpo.2950100504","article-title":"Transfusion of granulocyte rich buffy coats to neutropenic patients","volume":"10","author":"Reiss","year":"1982","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.tmrv.2025.150929_bib0035","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00006454-198409000-00003","article-title":"Neutrophil storage pool depletion in septic, neutropenic neonates","volume":"3","author":"Wheeler","year":"1984","journal-title":"Pediatr Infect Dis"},{"key":"10.1016\/j.tmrv.2025.150929_bib0036","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1542\/peds.79.3.422","article-title":"Buffy coat transfusions in neonates with sepsis and neutrophil storage pool depletion","volume":"79","author":"Wheeler","year":"1987","journal-title":"Pediatrics"},{"key":"10.1016\/j.tmrv.2025.150929_bib0037","first-page":"101","article-title":"Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases","volume":"11","author":"Cesaro","year":"2003","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.tmrv.2025.150929_bib0038","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/trf.14994","article-title":"The burden of invasive infections in neutropenic patients: incidence, outcomes, and use of granulocyte transfusions","volume":"59","author":"Netelenbos","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2025.150929_bib0039","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/vox.13170","article-title":"Therapeutic granulocyte infusion for patients with severe neutropaenia and neutrophilic dysfunction: New Zealand experience","volume":"117","author":"Chung","year":"2022","journal-title":"Vox Sanguinis"},{"key":"10.1016\/j.tmrv.2025.150929_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2024.104020","article-title":"GRAIN study - granulocytes against infections - use of granulocyte transfusion in haematopoietic stem cell transplant","volume":"63","author":"Rengaraj","year":"2024","journal-title":"Transfusion Apheresis Sci"},{"key":"10.1016\/j.tmrv.2025.150929_bib0041","first-page":"152","article-title":"A randomized controlled trial to explore the safety and efficacy of irradiated buffy-coat granulocytes in pediatric patients with febrile neutropenia","volume":"13","author":"Ramachandran","year":"2023","journal-title":"Am J Blood Res"},{"key":"10.1016\/j.tmrv.2025.150929_bib0042","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0002-9343(77)90200-5","article-title":"A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia","volume":"63","author":"Vogler","year":"1977","journal-title":"Am J Med"},{"key":"10.1016\/j.tmrv.2025.150929_bib0043","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s00431-016-2774-y","article-title":"Granulocyte transfusions in critically ill children with prolonged neutropenia: side effects and survival rates from a single-center analysis","volume":"175","author":"Weingarten","year":"2016","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.tmrv.2025.150929_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159569","article-title":"Dose-dependent effect of granulocyte transfusions in hematological patients with Febrile Neutropenia","volume":"11","author":"Teofili","year":"2016","journal-title":"PLOS ONE"},{"key":"10.1016\/j.tmrv.2025.150929_bib0045","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1007\/s00277-018-3432-4","article-title":"Clinical outcome of granulocyte transfusion therapy for the treatment of refractory infection in neutropenic patients with hematological diseases","volume":"97","author":"Zhou","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1016\/j.tmrv.2025.150929_bib0046","doi-asserted-by":"crossref","first-page":"e968","DOI":"10.1097\/MPH.0000000000002349","article-title":"Cui Bono? Identifying patient groups that may benefit from granulocyte transfusions in pediatric hematology and oncology","volume":"44","author":"Johann","year":"2022","journal-title":"J Pediat Hematol\/Oncol"},{"key":"10.1016\/j.tmrv.2025.150929_bib0047","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0022-3476(81)80556-2","article-title":"Polymorphonuclear leukocyte transfusion for the treatment of sepsis in the newborn infant","volume":"98","author":"Laurenti","year":"1981","journal-title":"J Pediat"},{"key":"10.1016\/j.tmrv.2025.150929_bib0048","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1046\/j.1537-2995.2002.00249.x","article-title":"Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors","volume":"42","author":"H\u00fcbel","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2025.150929_bib0049","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1423-0410.2006.00776.x","article-title":"Therapeutic transfusions of granulocytes collected by simple bag method for children with cancer and neutropenic infections: results of a single-centre pilot study","volume":"91","author":"Kikuta","year":"2006","journal-title":"Vox Sanguinis"},{"key":"10.1016\/j.tmrv.2025.150929_bib0050","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/annonc\/mdt110","article-title":"Granulocyte transfusions in hematologic malignancy patients with invasive pulmonary aspergillosis: outcomes and complications","volume":"24","author":"Raad","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.tmrv.2025.150929_bib0051","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1046\/j.1537-2995.1994.34394196620.x","article-title":"Granulocyte transfusions: efficacy in treating fungal infections in neutropenic patients following bone marrow transplantation","volume":"34","author":"Bhatia","year":"1994","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2025.150929_bib0052","doi-asserted-by":"crossref","DOI":"10.1177\/20406207251326765","article-title":"Effective engraftment via granulocyte transfusion in pre-engraftment febrile neutropenia following allogeneic hematopoietic stem cell transplantation: granulocyte transfusion as bridge therapy","volume":"16","author":"Mandaci \u015eanli","year":"2025","journal-title":"Therapeut Adv Hematol"},{"key":"10.1016\/j.tmrv.2025.150929_bib0053","first-page":"593","article-title":"Pulmonary complications in patients receiving granulocyte transfusions and amphotericin B","volume":"130","author":"Bow","year":"1984","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.tmrv.2025.150929_bib0054","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/ajh.2830310206","article-title":"Granulocyte transfusion therapy and amphotericin B: adverse reactions?","volume":"31","author":"Dutcher","year":"1989","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2025.150929_bib0055","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3109\/14653249.2010.529889","article-title":"Therapeutic granulocyte transfusions for the treatment of febrile neutropenia in patients with hematologic diseases: a 10-year experience at a single institute","volume":"13","author":"Kim","year":"2011","journal-title":"Cytotherapy"},{"key":"10.1016\/j.tmrv.2025.150929_bib0056","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1182\/blood.V57.1.90.90","article-title":"Concomitant administration of granulocyte transfusions and amphotericin B in neutropenic patients: absence of significant pulmonary toxicity","volume":"57","author":"Dana","year":"1981","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2025.150929_bib0057","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/10428194.2019.1660977","article-title":"Granulocyte transfusions - bridging to allogeneic hematopoietic stem cell transplantation","volume":"61","author":"Nguyen","year":"2020","journal-title":"Leukemia Lymphoma"},{"key":"10.1016\/j.tmrv.2025.150929_bib0058","first-page":"674","article-title":"The effect of granulocyte transfusion on engraftment in patients with allogeneic hematopoietic stem cell transplantation","volume":"6","author":"\u0130tme\u00e7","year":"2023","journal-title":"J Health Sci Med"},{"key":"10.1016\/j.tmrv.2025.150929_bib0059","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s12288-011-0078-y","article-title":"Hematopoietic stem cell transplantation in a very high risk group of patients with the support of granulocyte transfusion","volume":"27","author":"Yenicesu","year":"2011","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.tmrv.2025.150929_bib0060","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12077","article-title":"Neutrophils mediate Salmonella Typhimurium clearance through the GBP4 inflammasome-dependent production of prostaglandins","volume":"7","author":"Tyrkalska","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.tmrv.2025.150929_bib0061","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.4049\/jimmunol.0901541","article-title":"Neutrophil-derived hyperresistinemia in severe acute streptococcal Infections1","volume":"183","author":"Johansson","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2025.150929_bib0062","doi-asserted-by":"crossref","first-page":"e3455","DOI":"10.1371\/journal.pone.0003455","article-title":"Incompetence of neutrophils to invasive group A streptococcus is attributed to induction of plural virulence factors by dysfunction of a regulator","volume":"3","author":"Ato","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.tmrv.2025.150929_bib0063","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0273827","article-title":"Risk stratification by 30-day prognostic factors of clinical outcomes after granulocyte transfusion in acute myeloid leukemia: A single-center retrospective study","volume":"17","author":"Yoo","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.tmrv.2025.150929_bib0064","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/bmt.2008.237","article-title":"Randomized phase III study of granulocyte transfusions in neutropenic patients","volume":"42","author":"Seidel","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.tmrv.2025.150929_bib0065","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4103\/gjtm.gjtm_33_23","article-title":"Experience of granulocyte collections and transfusions in resource-constrained settings","volume":"8","author":"Mangwana","year":"2023","journal-title":"Glob J Transfusion Med"},{"key":"10.1016\/j.tmrv.2025.150929_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2021.103300","article-title":"Survival among children and adults treated with granulocyte transfusions: twenty years\u2019 experience at a Brazilian blood center","volume":"61","author":"De Almeida-Neto","year":"2022","journal-title":"Transfusion Apheresis Sci"},{"key":"10.1016\/j.tmrv.2025.150929_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2024.103106","article-title":"Neutrophils, an emerging new therapeutic platform","volume":"87","author":"L\u00f3pez-Arredondo","year":"2024","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.tmrv.2025.150929_bib0068","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1046\/j.1537-2995.2001.41020184.x","article-title":"Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs","volume":"41","author":"Platzbecker","year":"2001","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2025.150929_bib0069","first-page":"632","article-title":"Clinical efficacy and prediction of response to granulocyte transfusion therapy for patients with neutropenia-related infections","volume":"89","author":"Lee","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2025.150929_bib0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4999\/uhod.13080","article-title":"Donor granulocyte transfusions in febrile neutropenic pediatric oncology patients","volume":"24","author":"Sezgin","year":"2014","journal-title":"UHOD"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796325000549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796325000549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T12:07:57Z","timestamp":1765195677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796325000549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0887796325000549"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2025.150929","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Granulocyte Transfusions in Treating Neutropenic Infections: A Systematic Review and Meta-Analysis of Intervention Studies","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2025.150929","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"150929"}}